Search results
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoNovavax's filing is based on guidance from the FDA issued last week, which advised COVID-19 vaccine...
FDA advises vaccine manufacturers to make COVID-19 booster targeting KP.2 strain
ABC Action News Tampa Bay· 14 hours agoThe FDA has issued an updated recommendation for the fall COVID-19 vaccine formula. "Coverage in the...
Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths
Center for Infectious Disease Research and Policy· 8 hours agoThe authors compared outcomes among those who had received an updated XBB vaccine and those who had...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 4 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Summer COVID bump intensifies in L.A. and California, fueled by FLiRT variants
LA Times via AOL· 17 hours agoThe new COVID FLiRT subvariants are continuing to increase their dominance, fueling a rise in Los...
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 3 days agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
2 Beaten-Down Growth Stocks to Buy Without Hesitation in the 2024 Bull Market
Motley Fool via Yahoo Finance· 16 hours agoThe Stock Advisor service has more than quadrupled the return... has no position in any of the...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 4 days agoBooster shots improve immunity Pate urges people to stay up to date with COVID-19 vaccines. The...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 5 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
...Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
NewMediaWire via Yahoo Finance· 7 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...